A Nasal Treatment for COVID-19
NCT05799521 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-05-15
Summary
The goal of this study is to test an investigational new inhaled medication called Optate.
Conditions
- COVID-19
- Healthy
Interventions
- DRUG
-
Optate
Alkaline Buffer
- DRUG
-
Normal Saline
Sponsors & Collaborators
-
Indiana University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-27
- Primary Completion
- 2027-03-30
- Completion
- 2027-03-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Smell in Covid-19 and Efficacy of Nasal Theophylline
NCT04789499 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.
NCT04951349 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Inhaled Treatment in Sinusitis
NCT01907204 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection
NCT05109611 ·Status: TERMINATED ·Phase: PHASE3
-
Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19
NCT05599919 ·Status: COMPLETED ·Phase: PHASE3
-
Ivermectin Nasal Drops in Post COVID-19 Parosmia
NCT05269030 ·Status: UNKNOWN ·Phase: PHASE2
-
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
NCT05445921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
NCT04964414 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
480 Biomedical Sinus Drug Depot
NCT02967731 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Controlled Clinical Trial on the Use of Saline Nasal Irrigations to Eradicate Localized Nasal Infection by SARS-CoV-2
NCT05458336 ·Status: COMPLETED ·Phase: NA
-
Nasal Obstruction With Oxymetazoline and Corticosteroids
NCT06830109 ·Status: RECRUITING ·Phase: PHASE2
-
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
NCT06076304 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device
NCT01624662 ·Status: COMPLETED ·Phase: PHASE3
-
SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People
NCT06048393 ·Status: UNKNOWN ·Phase: PHASE1
-
Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects
NCT04431908 ·Status: COMPLETED
-
NasoNeb Delivery of an Intranasal Steroid
NCT01270256 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold
NCT01488604 ·Status: COMPLETED ·Phase: NA
-
Analysis of Impact on Nasal Obstruction by Commercially Available Internal Nasal Stents
NCT00683254 ·Status: WITHDRAWN
-
The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity
NCT00790972 ·Status: WITHDRAWN ·Phase: NA
-
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
NCT06008860 ·Status: RECRUITING ·Phase: PHASE4
-
Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms
NCT06198894 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19
NCT05541510 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety
NCT01622569 ·Status: COMPLETED ·Phase: PHASE3
-
Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection
NCT04443868 ·Status: WITHDRAWN ·Phase: PHASE2
-
Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
NCT02832362 ·Status: COMPLETED ·Phase: PHASE1